New pill targets Hard-to-Treat cancers in early trial
Disease control
Recruiting now
This study tests an experimental pill, VLS-1488, in people with advanced solid tumors that have not responded to other treatments. The goal is to find a safe dose and see if it can shrink tumors. About 200 adults with specific cancers like ovarian, lung, or breast cancer will tak…
Phase: PHASE1, PHASE2 • Sponsor: Volastra Therapeutics, Inc. • Aim: Disease control
Last updated May 03, 2026 20:00 UTC